To identify factors associated with readmission and development of an equation predicting unsuccessful discharge to enable more effective targeting of resources, decrease burden on hospitals and improve quality of care for the patients.
Introduction:
To identify factors associated with readmission and development of an equation predicting unsuccessful discharge to enable more effective targeting of resources, decrease burden on hospitals and improve quality of care for the patients.
Methods: Prospective Observational study conducted over 12 months between November 2013 and November 2014 on patients readmitted to MAPU in last 28 days from the first index admission in MAPU. Demographic data (age, gender, race, diagnosis on admission and re-admission, social circumstances) was collected along with data on patient's ADL, performance status, length of stay, number of co-morbidities and medications.
Results: Total number of patients studied was 179 with male to female ratio of 1:1.2 with mean age of 70.12 years. Of interest, 40% of people were either divorced or widowed. Around 70% of people were pensioners. 60% were current/reformed smokers and approximately half had history of moderate to heavy drinking. Significant proportion suffered from mood/anxiety disorders (40%). Most of the people were independent with activities of daily living and communication. But around half of the patients (48.6%) complained that pain limits their activity and nearly one-fifth had h/o falls. Around threefourth of patients were discharged on six or more medication on index admission with one-fourth of patients being discharged on opioids. Nearly half (48%) had high/very high Charlson's co-morbidity index with nearly two-thirds having more than two variables on Elixhauser index suggesting increased disease burden in this cohort. More than one-third (42%) had high LACE 1 score predisposing them to readmission. Most of the patients readmitted with the same diagnosis were admitted due to disease progression/complication despite optimum care. And most of the patients readmitted with different diagnosis were admitted due to new condition unrelated to the index admission. The relationship between re-admission status and other factors was tested with Chi-square tests for all categorical variables after dividing the cohort into two groups: one with ≤3 admissions and other with >3 admissions (86 vs 93 patients respectively). Significant relationship was found between number of re-admissions and LACE score, employment status, education and number of medications on discharge and high risk medications on discharge. A stepwise logistic regression with backward elimination found employment status, education, high risk medications as significant and LACE score almost significant predictors in the model.
Conclusions:
Our high risk patient group included elderly frail pensioners with increased burden of chronic diseases, social isolation, mood disorders, poor education and polypharmacy with previous h/o readmissions. De-prescribing, better patient/carer education, proper assessment and management of functional needs including pain, disability and comorbidities with transitional care strategies integrating pre-discharge needs assessment with post-discharge care may reduce the readmission rates. Background: The prescription rates of direct oral anticoagulants (DOACs) have steadily increased since their introduction as an alternative to warfarin. 1, 2 The reduced reliance on laboratory monitoring demands greater responsibility from the clinician to accurately dose these anticoagulants based on patient characteristics. One Australian study suggests the prescriptions of up to one-third of patients on DOACs may be inappropriate. 3 We sought to study the effect of a targeted educational intervention on the accuracy of DOAC prescriptions at a 621-bed tertiary teaching hospital.
DOSING ACCURACY OF DIRECT ORAL ANTICOAGULANTS: THE EFFECT OF AN EDUCATIONAL INTERVENTION
Methods: All inpatients prescribed a DOAC on discharge were identified from electronic hospital records. These records were reviewed and data on patient demographics, weight, serum creatinine, indication and prescribed dose of DOAC were extracted. The appropriate dose was determined using Product Information documents from the Therapeutic Goods Administration, based on varying factors for each agent including indication, age, weight, serum creatinine and creatinine clearance as calculated by the Cockcroft-Gault equation.
Pre-intervention data were collected from March to June 2016, followed by an educational campaign. This consisted of a survey distributed to all residents and awareness raising sessions with interns and ward pharmacists. Post-intervention DOAC dosing accuracy data were then collected for the months August to November 2016.
Results: 316 patients in the pre-intervention group and 453 patients in the post-intervention group were identified. 79 and 77 patients were excluded from their respective groups, due to insufficient data to ascertain the appropriate dose. A total of 237 patients in the pre-intervention group and 376 patients in the post-intervention periods were included for analysis.
Baseline characteristics were comparable for age and creatinine clearance between the groups, but not male gender (45.6% vs 55.6%, P = 0.02). 26.6% of the patients were prescribed incorrect doses in the preintervention group compared with 22.1% in the post-intervention group (P = 0.202). In the post-intervention group, a significantly higher proportion of patients newly commenced on DOACs were dosed appropriately compared with those on existing DOAC prescriptions (85% vs 72%, P < 0.05).
Conclusion:
Around 1 in 4 patients on DOACs were either under-or over-dosed. There was a small improvement in dosing accuracy after an educational intervention, in particular for those who were started on DOACs whilst inpatient. Ongoing quality improvement initiatives to improve DOAC prescription accuracy are required.
